Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

Abstract

Malignant astrocytomas are a deadly solid tumor in children. Limited understanding of their underlying genetic basis has contributed to modest progress in developing more effective therapies. In an effort to identify such alterations, we performed a genome-wide search for DNA copy number aberrations (CNA) in a panel of 33 tumors encompassing grade 1 through grade 4 tumors. Genomic amplifications of 10-fold or greater were restricted to grade 3 and 4 astrocytomas and included the MDM4 (1q32), PDGFRA (4q12), MET (7q21), CMYC (8q24), PVT1 (8q24), WNT5B (12p13), and IGF1R (15q26) genes. Homozygous deletions of CDKN2A (9p21), PTEN (10q26), and TP53 (17p3.1) were evident among grade 2 to 4 tumors. BRAF gene rearrangements that were indicated in three tumors prompted the discovery of KIAA1549-BRAF fusion transcripts expressed in 10 of 10 grade 1 astrocytomas and in none of the grade 2 to 4 tumors. In contrast, an oncogenic missense BRAF mutation (BRAF(V600E)) was detected in 7 of 31 grade 2 to 4 tumors but in none of the grade 1 tumors. BRAF(V600E) mutation seems to define a subset of malignant astrocytomas in children, in which there is frequent concomitant homozygous deletion of CDKN2A (five of seven cases). Taken together, these findings highlight BRAF as a frequent mutation target in pediatric astrocytomas, with distinct types of BRAF alteration occurring in grade 1 versus grade 2 to 4 tumors.

DOI: 10.1158/0008-5472.CAN-09-1851

Extracted Key Phrases

6 Figures and Tables

05001000150020102011201220132014201520162017
Citations per Year

5,699 Citations

Semantic Scholar estimates that this publication has 5,699 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Schiffman2010OncogenicBM, title={Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.}, author={Joshua Schiffman and John Graeme Hodgson and Scott VandenBerg and Patrick J. Flaherty and Mei-Yin C. Polley and Mamie Yu and Paul G Fisher and David H . Rowitch and James M. Ford and Mitchel S. Berger and Hanlee P. Ji and David H . Gutmann and C. David James}, journal={Cancer research}, year={2010}, volume={70 2}, pages={512-9} }